Apple Watch has revolutionized sleep tracking with a significant clinical upgrade. The tech giant has earned FDA clearance to market its latest Watches, featuring advanced sleep apnea detection capabilities. As of September 17, 2024, Apple Watch users in the US can benefit from the clinically-validated Breathing Disturbance analysis features available on both the new Watch 10 and its predecessors, including the Watch Series 9 and Ultra 2.
The highly-anticipated Apple Watch Series 10 is now available for pre-order through multiple retailers. Pricing starts at $489.99 for the sleek aluminum version, while the luxurious titanium variant in the latest Gold color is priced at $794. These premium prices are justified by the Watch 10’s cutting-edge sleep apnea-tracking abilities, which have garnered official FDA approval as an over-the-counter device to assess the risk of sleep apnea.
Apple has followed through on its promise to deliver innovative Breathing Disturbance features with watchOS 11, ensuring that users receive timely alerts about potential sleep apnea risks. This proactive approach aims to encourage more individuals to seek formal diagnosis and treatment for this potentially hazardous condition.
The combination of Apple’s robust health tracking ecosystem and FDA approval underscores the company’s commitment to enhancing user health and well-being. With these advancements, Apple Watch continues to set the standard for wearable technology, integrating sophisticated health monitoring features seamlessly into everyday life.
Pre-order the new Apple Watch Series 10 today to experience the future of health-focused wearable technology.
